Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Abramson Cancer Center at Penn Medicine
Prescient Therapeutics, Ltd.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Columbia University
Soligenix
Icahn School of Medicine at Mount Sinai
Stanford University
City of Hope Medical Center
Thomas Jefferson University
University College, London
4SC AG
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
University of Nebraska
Eastern Cooperative Oncology Group
Soligenix
Genmab
OncoSec Medical Incorporated
Genmab
Thomas Jefferson University
Mayo Clinic
miRagen Therapeutics, Inc.
Rochester Skin Lymphoma Medical Group, PLLC
European Organisation for Research and Treatment of Cancer - EORTC
Rochester General Hospital
Fred Hutchinson Cancer Center
Northwestern University
miRagen Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
National Cancer Institute (NCI)
University of Chicago
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Northwestern University
Case Comprehensive Cancer Center
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Neumedicines Inc.
M.D. Anderson Cancer Center
Wake Forest University Health Sciences